MMSI Merit Medical Systems, Inc.
USHealthcareAs of 2026-07-09 16:00
Why MMSI matters now
Merit Medical Systems, Inc. (MMSI) is a US stock in Healthcare. The latest InvestLog snapshot shows $71.46 with +0.56% on the session and $4.26B in market capitalization; recent performance reads 1-month +5.41% and YTD -23.73%.
The latest financial table shown here is Q1 2026, with revenue of $382.4M, net income of $41.0M, and EPS of $0.68. Investors can compare that operating picture with valuation signals such as P/E 31.18 and FCF yield 6.4%.
The latest indexable market news headline is "Here's Why You Should Add Merit Medical Stock to Your Portfolio Now" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $96.00; recent insider activity includes Voigt Michel J. filing G-Gift. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
31.18
PEG
4.61
P/B
2.46
P/S
2.60
EV/EBITDA
12.45
DCF Value
$147.33
FCF Yield
6.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
48.7%
Operating Margin
12.1%
Net Margin
9.0%
ROE
8.9%
ROA
5.1%
ROIC
5.6%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $382.4M | $41.0M | $0.68 |
| Q4 2025 | $394.2M | $38.0M | $0.63 |
| FY 2025 | $1.51B | $128.5M | $2.13 |
| Q3 2025 | $384.3M | $27.8M | $0.46 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$94.20
Target (Median)
$96.00
Target Range
$78.00 - $107.00
Trading Activity
Insider Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
US
Exchange
—
Beta
0.53
Merit Medical Systems, Inc. (MMSI) is engaged in the design, development, manufacturing, and worldwide commercialization of disposable medical products. These devices are crucial for a broad spectrum of diagnostic, therapeutic, and interventional procedures, primarily within the fields of cardiology, radiology, oncology, critical care, and endoscopy. The company operates through two main divisions: Cardiovascular and Endoscopy. Its extensive product portfolio includes advanced solutions for diagnosing and treating conditions in peripheral vessels and organs, as well as a comprehensive suite of cardiac intervention products. The latter encompasses tools for vascular access, angiography, electrophysiology, cardiac rhythm management, fluid and hemodynamic monitoring, hemostasis, and various interventional therapies for heart-related ailments. Additionally, MMSI provides customized procedural solutions, offering critical care items, disinfection protection systems, specialized syringes, manifold kits, and tailored trays and packs. Their offerings further extend to coated tubes and wires, alongside sophisticated sensor components for microelectromechanical systems (MEMS). The company also features pulmonary products, such as laser-cut tracheobronchial stents with their accompanying over-the-wire and direct visualization delivery systems, and dilation balloons used for endoscopic stricture dilation. Gastroenterology products, as well as essential kits and accessories for endoscopy and bronchoscopy procedures, complete their diverse catalog. Merit Medical Systems sells its products to a wide client base, including hospitals and healthcare professionals (physicians, technicians, and nurses) working in alternative care settings. Distribution channels include a direct sales force, authorized distributors, original equipment manufacturer (OEM) partnerships, and custom procedure tray manufacturers, reaching customers throughout the United States and internationally. Founded in 1987, Merit Medical Systems, Inc. has its corporate headquarters situated in South Jordan, Utah.